Press Coverage

Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults

6 June 2024

Mauna Kea Technologies and Metrodora Institute, a leading multispecialty healthcare institute, announced the formation of a new partnership.

This collaboration aims to establish Metrodora Institute as the first U.S. Center of Excellence that will serve as the model of patient care and physician training on the use of Cellvizio for identifying and treating food intolerances in patients suffering from Irritable Bowel Syndrome (IBS).

Read the complete article

Latest News

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

Mauna Kea Technologies Announces Nomination of 3 New Directors

Mauna Kea Technologies Announces Nomination of 3 New Directors

Publication of the 2025 Annual Financial Report 

Publication of the 2025 Annual Financial Report 

No results found.